Immunity Pharma Ltd.
PrivateTotal Funding Raised
$600,000
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Immunity Pharma Ltd. is a biotechnology company that develops peptide-based therapeutic drug candidates for the treatment of neurodegenerative diseases, with an initial focus on amyotrophic lateral sclerosis.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Immunity Pharma Ltd. Comparables
Compare Immunity Pharma Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Neuvivo | 78% | |
| QurAlis | 78% | |
| Spinogenix, Inc. | 76% |
Immunity Pharma Ltd. Funding Rounds
Historical fundraising activity
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 58% MoM, reaching 2.3K.
- Jul 27, 2026
Monthly visitors increased 155% MoM, reaching 1.5K.
Immunity Pharma Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Immunity Pharma Ltd.'s valuation, stock price, and market status.
Is Immunity Pharma Ltd. a public or private company?
Immunity Pharma Ltd. is a private company.
What is the current stock price of Immunity Pharma Ltd.?
Immunity Pharma Ltd. is a private company with no public stock price. No recent secondary market data is available.
How much is Immunity Pharma Ltd. worth (valuation)?
Valuation information for Immunity Pharma Ltd. is not publicly available.
Can I buy Immunity Pharma Ltd. stock?
Immunity Pharma Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Immunity Pharma Ltd.'s last funding round?
Funding round information for Immunity Pharma Ltd. is not publicly available.
Who are the main investors in Immunity Pharma Ltd.?
Investor information for Immunity Pharma Ltd. is not publicly disclosed.
Will Immunity Pharma Ltd. IPO soon?
No public IPO plans have been announced for Immunity Pharma Ltd..
How can I track Immunity Pharma Ltd. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Immunity Pharma Ltd.'s secondary market activity and sign up for updates.